Hormone replacement therapy and cancer: an update>
- 1 February 2003
- journal article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 12 (1) , 3-4
- https://doi.org/10.1097/00008469-200302000-00002
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Evidence from randomised trials on the long-term effects of hormone replacement therapyThe Lancet, 2002
- Menopausal Hormone Replacement Therapy and Risk of Ovarian CancerJAMA, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Noncardiovascular Disease Outcomes During 6.8 Years of Hormone TherapyJAMA, 2002
- A Clinical Trial of Estrogen-Replacement Therapy after Ischemic StrokeNew England Journal of Medicine, 2001
- Menopause, hormone replacement therapy and cancerMaturitas, 2001
- Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer RiskJAMA, 2000
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997